GATA3 and endometrial carcinoma: GATA3 expression is associated with favourable disease-free and overall survivals in breast cancers.10 However, GATA3 is a poor prognostic marker in neuroblastomas, endometrial carcinomas and soft tissue sarcomas.11, 12, 14 The underlying mechanisms of the distinct function of GATA3 still remain unclear.